Chiron Real Estate (XRN) Q2 2026 earnings — TrendMatrix coverage

Reported EPS

-$0.65

Estimate

-$0.40

Surprise

-62.3%

Score at report (before → after)

5.4 → 5.5/10

Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.

Chiron Real Estate (XRN) reported a wider loss than forecast — diluted EPS of -$0.65 against the -$0.40 estimate (a 62.3% shortfall). TrendMatrix's engine moved from Buy (Wait) (5.4/10) to Sell at 5.5/10 after the report — the engine's score rose despite the miss.

TrendMatrix currently rates XRN Sell at 5.7/10.

0 of the last 4 quarters beat the estimate; this quarter's -62.3% surprise compares with a -414.3% four-quarter average. Next scheduled report: 2026-11-03.

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current price

$37.15

Price target

$42.72

Stop

$34.97

Upside to target

+15.0%

Model outputs from TrendMatrix’s engine as of 2026-08-23 — shown for context, not personalized investment advice.

REIT quarters hinge on occupancy, rate exposure, and FFO rather than headline EPS, which mechanically distorts under depreciation.

Industry

REIT - Healthcare Facilities

Market cap

$537.9M

P/E (fwd)

-15.3

P/E (ttm)

10.0

52-week range

$29.05–$39.93

Off 52-week high

7.0%

RSI (14)

66

Volume vs avg

0.89×

Score today

5.7/10